The Effect of Coconut Oil on Alopecia
1 other identifier
interventional
86
1 country
1
Brief Summary
İn this study will be conducted to evaluate the effect of coconut oil on alopecia in 86 female breast cancer patients treated at Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital between 01.02.2025-31.12.2025.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable breast-cancer
Started Feb 2025
Shorter than P25 for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 3, 2025
CompletedFirst Submitted
Initial submission to the registry
February 5, 2025
CompletedFirst Posted
Study publicly available on registry
February 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2026
CompletedFebruary 12, 2025
February 1, 2025
11 months
February 5, 2025
February 8, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
National Cancer Instute (NCI) Common Terminology Criteria for Adverse Events (CTCAE); Alopecia
Grade 1; Hair loss of \<50% of normal for that individual that is not obvious from a distance but only on close inspection; a different hair style may be required to cover the hair loss but it does not require a wig or hair piece to camouflage Grade 2; Hair loss of \>=50% normal for that individual that is readily apparent to others; a wig or hair piece is necessary if the patient desires to completely camouflage the hair loss; associated with psychosocial impact
1-12 WEEK
Study Arms (2)
Experimental group
EXPERIMENTALAt the beginning of the study,patients will be asked to fill out an individual information form containing demographic information and disease process before the first chemotherapy application.The coconut oil application protocol will be explained to the patients in the experimental group and 10 milliliters of coconut oil will be applied to the hair follicles once a week. Alopecia assessment will be done every week.
Control Group
NO INTERVENTIONAt the beginning of the study,patients will be asked to fill out an individual information form containing demographic information and disease process before the first chemotherapy application. Patients in the control group will be asked not to apply anything to their hair. In each subsequent week, the presence of hair loss of the patients will be evaluated with the alopecia evaluation scale.
Interventions
The coconut oil application protocol will be explained to the patients in the experimental group and 10 milliliters of coconut oil will be applied to the hair follicles once a week. Alopecia assessment will be done every week.
Eligibility Criteria
You may qualify if:
- To have been diagnosed with breast cancer.
- The chemotherapy treatment plan should be planned as the Doxorubicin-Cyclophosphamide protocol.
- Volunteer to participate in the study.
- Be 18 years of age or older.
- Being a woman.
You may not qualify if:
- Having any health problem or disability that prevents communication (vision-hearing problems, neurological, psychiatric diseases).
- Planning other treatments other than the Doxorubicin-Cyclophosphamide protocol for the treatment of breast cancer.
- Not volunteering to participate in the study.
- Having previously experienced any disease/skin problem that causes hair loss.
- Having received chemotherapy before.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dr. Abdurrahman Yurtaslan Ankara Onkoloji Eğitim ve Araştırma Hastanesi
Ankara, Yenimahalle, 06170, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Masking Details
- Patients with breast cancer in the experimental and control groups will be masked.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Nurse
Study Record Dates
First Submitted
February 5, 2025
First Posted
February 10, 2025
Study Start
February 3, 2025
Primary Completion
December 31, 2025
Study Completion
January 31, 2026
Last Updated
February 12, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share